Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | GDA | Q9Y2T3 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.44 |
| ▸ | RUNX1 | Q01196 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL932546 | 1.00 | KDM4E (0.46) | KDM4EALDH1A1BLMTDP1PMP22 | |
| Hydrochloric Acid SCHEMBL28868510 | 0.98 | KDM4E (0.44) | KDM4EALDH1A1BLMTDP1PMP22 | |
| Hydrochloric Acid SCHEMBL30431695 | 0.98 | KDM4E (0.44) | KDM4EALDH1A1BLMTDP1PMP22 | |
| Water SCHEMBL6479622 | 0.98 | KDM4E (0.44) | KDM4EALDH1A1BLMTDP1PMP22 | |
| SCHEMBL9435433 | 0.89 | RPS6KA3 (0.41) | KDM4EALDH1A1BLMTDP1PMP22 | |
| Pterine SCHEMBL1512995 | 0.82 | HSD17B10 (0.46) | KDM4EALDH1A1PMP22HSD17B10MEN1 | |
| SCHEMBL30572345 | 0.80 | GDA (0.44) | KDM4EALDH1A1BLMTDP1PMP22 | |
| SCHEMBL340668 | 0.80 | GDA (0.44) | KDM4EALDH1A1BLMTDP1PMP22 | |
| SCHEMBL3961933 | 0.80 | GDA (0.44) | KDM4EALDH1A1BLMTDP1PMP22 | |
| SCHEMBL5441685 | 0.78 | KDM4E (0.42) | KDM4EALDH1A1BLMTDP1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151713-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025151711-A1 | NUCLEIC ACID VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250222082-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | ARKEA BIO CORP (US) | 2025-07-10 | — | — | US | claimed |
| WO-2025128700-A1 | CELL-BASED VACCINES | Arkea Bio Corp. (US) | 2025-06-19 | — | — | WO | claimed |
| EP-4554616-A1 | COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS | Arkea Bio Corp. (US) | 2025-05-21 | — | — | EP | claimed |
| WO-2024182781-A1 | CORONAVIRUS COMPOSITIONS AND USES THEREOF | Vir Biotechnology, Inc. (US) | 2024-09-06 | — | — | WO | claimed |
| US-20240189408-A1 | COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS | Arkea Bio Corp. | 2024-06-13 | — | — | US | claimed |
| WO-2024015366-A1 | COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS | Arkea Bio Corp. (US) | 2024-01-18 | — | — | WO | claimed |
| CN-112979826-B | Encephalitis B virus nanoparticle vaccine and preparation method and application thereof | 华中农业大学 | 2022-04-08 | — | — | CN | claimed |
| EP-3674295-B1 | HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD (KR) | 2026-04-29 | — | — | EP | disclosed |
| US-12365782-B2 | Compositions and methods for the degradation of waste polypropylene | NOVOLOOP, INC. (US) | 2025-07-22 | — | — | US | disclosed |
| WO-2025151713-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | disclosed |
| WO-2025151711-A1 | NUCLEIC ACID VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | disclosed |
| US-20250222082-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | ARKEA BIO CORP (US) | 2025-07-10 | — | — | US | disclosed |
| US-20220306829-A1 | COMPOSITIONS AND METHODS FOR THE DEGRADATION OF WASTE POLYPROPYLENE | NOVOLOOP INC (US) | 2022-09-29 | — | — | US | disclosed |
| CN-113582873-B | Method for preparing N-benzyl enamine by efficiently photo-catalytically oxidizing benzylamine | 大连理工大学 | 2022-09-06 | — | — | CN | disclosed |
| WO-2022133259-A2 | IMMUNOGENIC COMPOSITIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022133255-A2 | IMMUNOGENIC COMPOSITIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2022-06-23 | — | — | WO | disclosed |
| CN-114630698-A | Engineered HCV E2 immunogens and related vaccine compositions | 斯克里普斯研究学院 | 2022-06-14 | — | — | CN | disclosed |
| CN-112979826-B | Encephalitis B virus nanoparticle vaccine and preparation method and application thereof | 华中农业大学 | 2022-04-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250222082-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | MCRS1, VIP, HM13 | KDM4E 4403/4885ALDH1A1 4837/4885BLM 2678/4885 |
| US-20240189408-A1 | COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS | MT-CO2, CYB5R3, COX5A | KDM4E 1943/4885ALDH1A1 1529/4885BLM 2636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.